Free Trial

Michael Weinstein Analyst Performance

Analyst at JPMorgan Chase & Co.

Michael Weinstein is a stock analyst at JPMorgan Chase & Co. focused in the medical sector, covering 13 publicly traded companies. Over the past year, Michael Weinstein has issued 1 stock ratings, including and hold recommendations. While full access to Michael Weinstein's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Weinstein's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
36 Last 11 Years
Buy Recommendations
55.56% 20 Buy Ratings
Companies Covered
13 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy55.6%20 ratings
Hold41.7%15 ratings
Sell2.8%1 ratings

Out of 36 total stock ratings issued by Michael Weinstein at JPMorgan Chase & Co., the majority (55.6%) have been Buy recommendations, followed by 41.7% Hold and 2.8% Sell.

Exchange Coverage

ExchangePercentageCount
NYSE
76.9% of companies on NYSE
10 companies
NASDAQ
23.1% of companies on NASDAQ
3 companies

Michael Weinstein, an analyst at JPMorgan Chase & Co., currently covers 13 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
10 companies
76.9%
Miscellaneous
3 companies
23.1%

Michael Weinstein of JPMorgan Chase & Co. specializes in stock coverage within the Medical sector, with additional focus on companies.

Coverage Industries

IndustryPercentage
MED PRODUCTS
3 companies
23.1%
Miscellaneous
3 companies
23.1%
MED INSTRUMENTS
2 companies
15.4%
SURGICAL & MEDICAL INSTRUMENTS
2 companies
15.4%
LARGE CAP PHARMA
1 company
7.7%
MEDICAL DEVICES
1 company
7.7%
MED/DENTAL - SUPP
1 company
7.7%

Michael Weinstein's Ratings History at JPMorgan Chase & Co.

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
9/16/2025Boost Price Target$176.48$200.00Neutral